Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Management of pulmonary embolism at a large academic hospital.

Freeland ZK, Clayton JT, Rosenblatt RL.

Proc (Bayl Univ Med Cent). 2018 Nov 16;32(1):9-13. doi: 10.1080/08998280.2018.1503476. eCollection 2019 Jan.

PMID:
30956571
2.

Clinical and morphologic features of acute, subacute and chronic cor pulmonale (pulmonary heart disease).

Roberts WC, Shafii AE, Grayburn PA, Ko JM, Weissenborn MR, Rosenblatt RL, Guileyardo JM.

Am J Cardiol. 2015 Mar 1;115(5):697-703. doi: 10.1016/j.amjcard.2014.12.002. Epub 2014 Dec 18.

PMID:
25727086
3.

Bilateral diaphragmatic paralysis associated with the use of the tumor necrosis factor-alpha inhibitor adalimumab.

Benjamin MM, Martin AW, Rosenblatt RL.

Proc (Bayl Univ Med Cent). 2014 Apr;27(2):113-5.

4.

Cardiac restriction secondary to massive calcific deposits in the left ventricular cavity.

Roberts WC, Rosenblatt RL, Ko JM, Grayburn PA, Kuiper JJ, Guileyardo JM.

Am J Cardiol. 2014 Apr 15;113(8):1442-6. doi: 10.1016/j.amjcard.2013.12.047. Epub 2014 Feb 1.

PMID:
24576543
5.

Chylopericardium following orthotopic lung transplantation.

Wait MA, Ramsay MA, Hardaway BW, Capehart JE, Rosenblatt RL.

Proc (Bayl Univ Med Cent). 2013 Jul;26(3):280-2.

6.

Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.

Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee; Cystic Fibrosis Foundation Pulmonary Therapies Committee.

Am J Respir Crit Care Med. 2010 Aug 1;182(3):298-306. doi: 10.1164/rccm.201002-0157CI.

PMID:
20675678
7.

Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations.

Diaz de Leon A, Cronkhite JT, Katzenstein AL, Godwin JD, Raghu G, Glazer CS, Rosenblatt RL, Girod CE, Garrity ER, Xing C, Garcia CK.

PLoS One. 2010 May 19;5(5):e10680. doi: 10.1371/journal.pone.0010680.

8.

Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.

Flume PA, Mogayzel PJ Jr, Robinson KA, Goss CH, Rosenblatt RL, Kuhn RJ, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee.

Am J Respir Crit Care Med. 2009 Nov 1;180(9):802-8. doi: 10.1164/rccm.200812-1845PP. Epub 2009 Sep 3. Review.

PMID:
19729669
9.

Lung transplantation in cystic fibrosis.

Rosenblatt RL.

Respir Care. 2009 Jun;54(6):777-86; discussion 786-7. Review.

10.

Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.

Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, Rosenblatt RL, DiMaio JM, Kinch LN, Grishin NV, Garcia CK.

Am J Hum Genet. 2009 Jan;84(1):52-9. doi: 10.1016/j.ajhg.2008.11.010. Epub 2008 Dec 18.

11.

Telomere shortening in familial and sporadic pulmonary fibrosis.

Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, Garcia CK.

Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37. doi: 10.1164/rccm.200804-550OC. Epub 2008 Jul 17.

12.

Adult-onset pulmonary fibrosis caused by mutations in telomerase.

Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, Weissler JC, Rosenblatt RL, Shay JW, Garcia CK.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7552-7. Epub 2007 Apr 25.

13.

Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival.

Rosenbaum DH, Bhojani RA, Dikmen E, Kaiser PA, Paul MC, Wait MA, Meyer DM, Jessen ME, Yancy CW, Rosenblatt RL, Torres F, Perkins S, Ring WS, DiMaio JM.

J Heart Lung Transplant. 2005 Dec;24(12):2043-7.

PMID:
16364847
14.

Inhibition of neutral sodium absorption by a prostaglandin analogue in patients with cystic fibrosis.

Coates SW Jr, Högenauer C, Santa Ana CA, Rosenblatt RL, Emmett M, Fordtran JS.

Gastroenterology. 2004 Jul;127(1):65-72.

PMID:
15236173
15.

Abnormal passive chloride absorption in cystic fibrosis jejunum functionally opposes the classic chloride secretory defect.

Russo MA, Hogenauer C, Coates SW Jr, Santa Ana CA, Porter JL, Rosenblatt RL, Emmett M, Fordtran JS.

J Clin Invest. 2003 Jul;112(1):118-25.

16.

Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: an evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion.

Högenauer C, Santa Ana CA, Porter JL, Millard M, Gelfand A, Rosenblatt RL, Prestidge CB, Fordtran JS.

Am J Hum Genet. 2000 Dec;67(6):1422-7. Epub 2000 Oct 30.

17.

An individualized protocol is more accurate than a standard protocol for assessing exercise capacity after heart transplantation.

Olivari MT, Yancy CW, Rosenblatt RL.

J Heart Lung Transplant. 1996 Nov;15(11):1069-74.

PMID:
8956115
18.

Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.

Olivari MT, Jessen ME, Baldwin BJ, Horn VP, Yancy CW, Ring WS, Rosenblatt RL.

J Heart Lung Transplant. 1995 Jan-Feb;14(1 Pt 1):127-35.

PMID:
7727461

Supplemental Content

Loading ...
Support Center